Aryaman Capital (538716)

Score breakdown: P/E: 2/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Let's judge Aryaman Capital as a piece of business, not a market quote. It is a small investment company with a market cap of ₹201 Cr, so any purchase must be made with trepidation. The reported ROE is eye-catching at 51.05% and ROCE is 31.72%, but these are on a book value of only ₹48.71. When I see sales down 35.13% and profits down 50.43%, I don't celebrate high ROE—I question how long it can last. The latest quarter shows ₹15 Cr of sales and ₹6 Cr of net profit, a 40% margin, but investment-company earnings are fickle. At ₹167.55, the P/E is 17.83 and the price-to-book is 3.44. For a business whose earnings have just been cut in half, that is not cheap. The Piotroski F-Score of 3/9 is a loud warning: the financial health is deteriorating. There is also zero dividend, so the minority shareholder receives no income while waiting. Promoter holding is not disclosed—something I dislike intensely in Indian markets. The stock has fallen roughly 78% from its 52-week high of ₹753.85, which tells me the market has already lost enthusiasm. Graham would insist on a margin of safety; at 3.44 times book with falling sales and weak fundamentals, I don't find one. This looks like a cyclical investment business, not a durable compounder. I need evidence that revenues have stabilised, that management can deploy capital profitably, and that the balance sheet remains sound. Without those, I'll watch from the sidelines.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer